Eckert & Ziegler SE Stock London S.E.

Equities

0NZY

DE0005659700

Office Equipment

Market Closed - London S.E. 11:30:00 2024-06-07 am EDT 5-day change 1st Jan Change
48.44 EUR -0.46% Intraday chart for Eckert & Ziegler SE +5.41% +17.32%
Sales 2024 * 271M 293M Sales 2025 * 296M 320M Capitalization 1B 1.08B
Net income 2024 * 34M 36.72M Net income 2025 * 36M 38.88M EV / Sales 2024 * 3.54 x
Net cash position 2024 * 43.4M 46.87M Net cash position 2025 * 42.6M 46.01M EV / Sales 2025 * 3.24 x
P/E ratio 2024 *
29 x
P/E ratio 2025 *
27.2 x
Employees 1,072
Yield 2024 *
1.04%
Yield 2025 *
1.04%
Free-Float 67.02%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Eckert & Ziegler SE

1 day-0.46%
1 week+5.41%
Current month+5.41%
1 month+21.11%
3 months+28.18%
6 months+29.65%
Current year+17.32%
More quotes
1 week
45.58
Extreme 45.58
49.04
1 month
39.30
Extreme 39.3
49.04
Current year
32.72
Extreme 32.72
49.04
1 year
29.00
Extreme 29
49.04
3 years
29.00
Extreme 29
140.75
5 years
23.93
Extreme 23.925
140.75
10 years
4.60
Extreme 4.6
140.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 16-12-31
Founder 55 96-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 71 18-12-31
Founder 55 96-12-31
Director/Board Member 71 19-05-28
More insiders
Date Price Change Volume
24-06-07 48 -1.32% 150,403
24-06-06 48.64 +1.30% 1,137
24-06-05 48.02 +0.48% 7,061
24-06-04 47.79 +3.72% 25,798
24-06-03 46.08 +0.26% 5,146

Delayed Quote London S.E., June 07, 2024 at 11:30 am EDT

More quotes
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
48.14 EUR
Average target price
62.5 EUR
Spread / Average Target
+29.83%
Consensus

Annual profits - Rate of surprise